Document is current
Any future updates will be listed below
-
Authors
Nakagami, Yuki
Hazama, Shoichi
Suzuki, Nobuaki
Yoshida, Shin
Tomochika, Shinobu
Matsui, Hiroto
Shindo, Yoshitaro
Tokumitsu, Yukio
Matsukuma, Satoshi
Watanabe, Yusaku
Iida, Michihisa
Tsunedomi, Ryouichi
Takeda, Shigeru
Fujita, Tomonobu
Kawakami, Yutaka
Ogihara, Hiroyuki
Hamamoto, Yoshihiko
Ioka, Tatsuya
Tanabe, Tsuyoshi
Ueno, Tomio
Nagano, Hiroaki
-
Funding
Funding for this research was provided by:
YAMAGUCHI UNIVERSITY FUND
Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT: 11039020, P-DIRECT: 11039020)
Japan Agency for Medical Research and Development (AMED: 15cm0106085h0005, AMED: 15cm0106085h0005)
Leading Advanced Projects for Medical Innovation (LEAP: 16am0001006h0003, LEAP: 16am0001006h0003)
- License Information
-
More Information
Article History
Received: 29 April 2022
Accepted: 6 October 2022
First Online: 18 October 2022
Declarations
:
: Ethical, legal, and social implications were approved by the Ethics Committee of Yamaguchi University Hospital (H17-83 and H23-135). This study was conducted per the Helsinki Declaration for experimentation on human subjects. All the samples were obtained with informed consent from the patients.
: Not applicable.
: All authors declare no competing interests.
